Healthcare Sales & Marketing Network News: Ocular Therapeutix

Searching News Database: Ocular Therapeutix

HSMN NewsFeed - 13 Oct 2016
Ocular Therapeutix(TM) and Regeneron Enter Into Strategic Collaboration to Develop Sustained Release Formulation of Aflibercept for the Treatment of Wet AMD and Other Serious Retinal Diseases
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 10 Jun 2013
Baxter Ventures Invests in Ocular Therapeutix, Inc.
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 25 Feb 2013
Ocular Therapeutix Completes PMA Submission for ReSure(R) Sealant
Devices Ophthalmology Wound Care FDA

HSMN NewsFeed - 28 Jan 2013
Ocular Therapeutix, Inc. Closes on $23.8 Million Series D Extension
Devices Drug Delivery Ophthalmology Venture Capital

HSMN NewsFeed - 2 Feb 2011
Ocular Therapeutix, Inc. Completes Series D Financing to Support Phase II Sustained Drug Delivery Clinical Trials
Devices Drug Delivery Ophthalmology Venture Capital

HSMN NewsFeed - 12 Oct 2010
Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
Devices Ophthalmology Drug Delivery

HSMN NewsFeed - 1 Oct 2009
Ocular Therapeutix, Inc. Appoints Two New Board Members
Devices Ophthalmology Personnel

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.